{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-048477","form_type":"8-K","ticker":"VSEE","cik":"0001864531","company_name":"VSEE HEALTH, INC.","filed_at":"2024-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.964746+00:00","generated_at":"2026-06-03T19:33:42.472981+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Digital Health Acquisition extends business combination deadline to June 30, 2024","bullets":["Second Amendment to Third A&R BCA extends termination date from March 31, 2024 to June 30, 2024.","Bridge Notes (principal $111,111.33 and $55,555.67) maturity also extended to June 30, 2024 via Bridge Letter Agreement.","Extension Note (principal $300,000) maturity extended to June 30, 2024 via Extension Letter Agreement.","Parties include DHAC, Merger Subs, VSee Lab, iDoc, and respective institutional investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-048477","json":"https://secwatch.observer/filing/0001104659-24-048477.json","markdown":"https://secwatch.observer/filing/0001104659-24-048477.md","text":"https://secwatch.observer/filing/0001104659-24-048477.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1864531/000110465924048477/0001104659-24-048477-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1864531/000110465924048477/tm2411992d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T19:33:42.472981+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01977f554160f8cb0e8596a804b99decffcdaded","claim":"VSEE HEALTH, INC. amended Bridge Letter Agreement with the Bridge Investor (effective 2024-04-17).","evidence_excerpt":"On April 17, 2024, the Company, VSee, and iDoc entered into a letter agreement with the Bridge Investor (the “Bridge Letter Agreement”), which amended the date with respect to the termination or closing of the business combination referenced in the Bridge Notes from March 31, 2024 to June 30, 2024","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465924048477/0001104659-24-048477-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"the Bridge Investor"},{"label":"Effective","value":"2024-04-17"}],"fact_type":"material_agreement"},{"claim_id":"1fb0a10c213666742111291058514e5bf4851c16","claim":"VSEE HEALTH, INC. entered into Third Amended and Restated Business Combination Agreement with Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., iDoc Virtual Telehealth Solutions, Inc. (effective 2023-11-21).","evidence_excerpt":"Digital Health Acquisition Corp. (“DHAC” or the “Company”), DHAC Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of DHAC (“Merger Sub I”), DHAC Merger Sub II, Inc., a Texas corporation and a wholly owned subsidiary of DHAC (“Merger Sub II” and together with Merger Sub I, the “Merger Subs”), VSee Lab, Inc., a Delaware corporation (“VSee”), and iDoc Virtual Telehealth Solutions, Inc., a Texas corporation (“iDoc” and together with DHAC, Merger Sub I, Merger Sub II, VSee and iDoc, the “Parties”), entered into a Third Amended and Restated Business Combination Agreement on November 21, 2023","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465924048477/0001104659-24-048477-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., iDoc Virtual Telehealth Solutions, Inc."},{"label":"Effective","value":"2023-11-21"}],"fact_type":"material_agreement"},{"claim_id":"6c0a698477d8c14b885a04bbca54d8c5ed00c066","claim":"VSEE HEALTH, INC. amended Second Amendment with Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., iDoc Virtual Telehealth Solutions, Inc. (effective 2024-04-17).","evidence_excerpt":"On April 17, 2024, the Parties entered into a Second Amendment (the “Second Amendment”) to the Business Combination Agreement, pursuant to which the termination date in the Business Combination Agreement was amended from March 31, 2024 to June 30, 2024","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465924048477/0001104659-24-048477-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., iDoc Virtual Telehealth Solutions, Inc."},{"label":"Effective","value":"2024-04-17"}],"fact_type":"material_agreement"},{"claim_id":"9588244184158110f9050d1315fd38578d105db8","claim":"VSEE HEALTH, INC. amended Extension Letter Agreement with an institutional and accredited investor (effective 2024-04-17).","evidence_excerpt":"On April 17, 2024, the Company and the investor entered into a letter agreement (the “Extension Letter Agreement”), which amended the maturity date of the Extension Note to June 30, 2024 and clarified certain definitions and transaction terms in both the Extension Purchase Agreement and the Extension Note","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1864531/000110465924048477/0001104659-24-048477-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"an institutional and accredited investor"},{"label":"Effective","value":"2024-04-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}